SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen

By Campo R.   DeJesus E.   Bredeek U. F.   Henry K.   Khanlou H.   Logue K.   Brinson C.   Benson P.   Dau L.   Wang H.   White K.   Flaherty J.   Fralich T.   Guyer B.   Piontkowsky D.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1637-1645

Oxford University Press

Access to resources Recommend Favorite

Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients

By  

Current HIV Research, Vol. 15, Iss. 6, 2018-01 ,pp. : 448-455

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL study

By Masiá Mar   Martínez Esteban   Padilla Sergio   Gatell José M.   Gutiérrez Félix  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 409-413

Oxford University Press

Access to resources Recommend Favorite

Creatine kinase elevation in HIV-1-infected patients receiving raltegravir-containing antiretroviral therapy: a cohort study

By Monteiro Polyana   Perez Iñaki   Pich Judit   Gatell Jose Maria   Martínez Esteban  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 404-408

Oxford University Press

Access to resources Recommend Favorite

Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study

By  

Current HIV Research, Vol. 6, Iss. 1, 2008-01 ,pp. : 59-64

Bentham Science Publishers

Access to resources Recommend Favorite